Digital Mammographic Imaging Screening Trial

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Digital Mammographic Imaging Screening Trial (DMIST), is a multi-institutional research study on the efficacy for screening of Full Field digital mammography compared to conventional film-screen mammography that was sponsored by the U.S. National Cancer Institute and performed by ACRIN.

The findings[1][2] that FFDM was not inferior to the existing technology, and potentially superior in younger women with dense breasts, has led to a rapid proliferation of digital systems in the US.

References[edit]

  1. ^ Pisano (27 Oct 2005). "Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening". NEJM. Retrieved 11 Feb 2010. 
  2. ^ Berry (27 Oct 2005). "Film or Digital Mammographic Screening?". NEJM. Retrieved 11 Feb 2010. 

External links[edit]